Phreesia (NYSE:PHR – Get Free Report) and RTCORE (OTCMKTS:RTME – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.
Risk & Volatility
Phreesia has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, RTCORE has a beta of 8.34, suggesting that its stock price is 734% more volatile than the S&P 500.
Valuation & Earnings
This table compares Phreesia and RTCORE”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Phreesia | $419.81 million | 3.51 | -$136.88 million | ($1.02) | -24.87 |
RTCORE | N/A | N/A | N/A | N/A | N/A |
Analyst Ratings
This is a summary of current ratings for Phreesia and RTCORE, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Phreesia | 0 | 0 | 12 | 0 | 3.00 |
RTCORE | 0 | 0 | 0 | 0 | 0.00 |
Phreesia currently has a consensus price target of $31.33, suggesting a potential upside of 23.51%. Given Phreesia’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Phreesia is more favorable than RTCORE.
Profitability
This table compares Phreesia and RTCORE’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Phreesia | -20.43% | -32.78% | -22.37% |
RTCORE | N/A | N/A | N/A |
Institutional and Insider Ownership
92.1% of Phreesia shares are held by institutional investors. 5.8% of Phreesia shares are held by company insiders. Comparatively, 41.3% of RTCORE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
About Phreesia
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
About RTCORE
RTCORE Inc provides software solutions. It engages in the development of Real Time Core Processing System, a cloud-native software to displace the monolithic systems plaguing industries worldwide. The company was formerly known as iSocialy, Inc. and changed its name to RTCORE Inc in September 2020. RTCORE Inc is headquartered in Charlotte, North Carolina.
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.